Cargando…

Adverse pregnancy outcomes and subsequent risk of cardiovascular disease in women with systemic lupus erythematosus

Mostrar otras versiones (1)

BACKGROUND/OBJECTIVE: Patients with systemic lupus erythematosus (SLE) are at increased risk for adverse pregnancy outcomes and cardiovascular disease (CVD). The objective of this exploratory study was to investigate the association between a history of adverse pregnancy outcomes and subsequent risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Pin, Rhew, Elisa, Ness, Roberta B, Peaceman, Alan, Dyer, Alan, McPherson, David, Kondos, George T, Edmundowicz, Daniel, Sutton-Tyrrell, Kim, Thompson, Trina, Ramsey-Goldman, Rosalind
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Reproductive health and APS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213826/ https://www.ncbi.nlm.nih.gov/pubmed/25379191 http://dx.doi.org/10.1136/lupus-2014-000024

Ejemplares similares

Adverse pregnancy outcomes and subsequent risk of cardiovascular disease in women with systemic lupus erythematosus
por: Lin, Pin, et al.
Publicado: (2014)

Anti-Müllerian hormone in African-American women with systemic lupus erythematosus
por: Angley, Meghan, et al.
Publicado: (2020)

Pregnancy outcomes among African–American patients with systemic lupus erythematosus compared with controls
por: Barnado, April, et al.
Publicado: (2014)

Effectiveness of a multidisciplinary clinical pathway for women with systemic lupus erythematosus and/or antiphospholipid syndrome
por: Wind, Merlijn, et al.
Publicado: (2021)

Increased usage of special educational services by children born to mothers with systemic lupus erythematosus and antiphospholipid antibodies
por: Marder, Wendy, et al.
Publicado: (2014)

Impact of pregnancy in patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: case series and literature review
por: Li, Mucong, et al.
Publicado: (2022)

Characteristics related to early secondary amenorrhoea and pregnancy among women diagnosed with systemic lupus erythematosus: an analysis using the GOAL study
por: Knight, Jessica H, et al.
Publicado: (2016)

Placental histology and neutrophil extracellular traps in lupus and pre-eclampsia pregnancies
por: Marder, Wendy, et al.
Publicado: (2016)

Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomes
por: Balevic, Stephen J, et al.
Publicado: (2022)

Hydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data
por: Clowse, Megan E B, et al.
Publicado: (2022)

Lupus anticoagulant, disease activity and low complement in the first trimester are predictive of pregnancy loss
por: Mankee, Anil, et al.
Publicado: (2015)

Risk factors for changes in carotid intima media thickness and plaque over 5 years in women with systemic lupus erythematosus
por: Lertratanakul, Apinya, et al.
Publicado: (2021)

Inflammatory expression profiles in monocyte-to-macrophage differentiation in patients with systemic lupus erythematosus and relationship with atherosclerosis
por: Korman, Benjamin D, et al.
Publicado: (2014)

Soluble E-selectin may predict progression of subclinical atherosclerosis, as measured by coronary artery calcium score and aorta calcium score, in women with systemic lupus erythematosus
por: Lertratanakul, A, et al.
Publicado: (2012)

Breastfeeding in women with rheumatic diseases
por: Ikram, Naira, et al.
Publicado: (2021)

Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (‘Registry’)
por: Erton, Zeynep Belce, et al.
Publicado: (2022)

Therapy with direct oral anticoagulants for secondary prevention of thromboembolic events in the antiphospholipid syndrome: a systematic review and meta-analysis of randomised trials
por: Adelhelm, Josefine B H, et al.
Publicado: (2023)

Serum α-chlorofatty acid as a biomarker for baseline subclinical cardiovascular disease in systemic lupus erythematosus
por: Mahieu, MA, et al.
Publicado: (2012)

Recommendations for rapid sequence induction in Europe – How standardized is the standard of care?
por: Wetsch, Wolfgang, et al.
Publicado: (2013)

Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosus
por: Dasgupta, Sudeshna, et al.
Publicado: (2011)

Atypical Findings of Focal Nodular Hyperplasia with Gadoxetic Acid (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging
por: Yoon, Jung-Hee, et al.
Publicado: (2014)

Estado actual de los tratamientos para la COVID-19
por: Llover, Mariona Nadal, et al.
Publicado: (2021)

Mantenimiento de tratamientos crónicos en pacientes afectados de COVID-19
por: Sánchez, Jesús M. Redondo, et al.
Publicado: (2021)

Dialogue: what can we learn about the relationship between systemic lupus erythematosus and haematological malignancies from linking disease registries?
por: Ramsey-Goldman, Rosalind, et al.
Publicado: (2014)

Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology–Classified Systemic Lupus Erythematosus
por: Ramsey‐Goldman, Rosalind, et al.
Publicado: (2019)

Hypertensive disorders of pregnancy and subsequent maternal cardiovascular health
por: Bergen, Nienke E., et al.
Publicado: (2018)

Standardised incidence ratios (SIRs) for cancer after renal transplant in systemic lupus erythematosus (SLE) and non-SLE recipients
por: Ramsey-Goldman, Rosalind, et al.
Publicado: (2016)

Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis
por: Bernatsky, S, et al.
Publicado: (2011)

Reduction in erythrocyte-bound complement activation products and titres of anti-C1q antibodies associate with clinical improvement in systemic lupus erythematosus
por: Buyon, Jill, et al.
Publicado: (2016)

Identification and assessment of classification criteria attributes for systemic lupus erythematosus in a regional medical record data network
por: Forrest, Noah, et al.
Publicado: (2023)

Vitamin D in Lupus Patients of Childbearing Age: Are We Doing Enough?
por: Statache, Gianina, et al.
Publicado: (2022)

Utilizing in ovo telemetry to examine the effects of reduced incubation temperature on broiler embryo temperature and subsequent hatchability
por: Lindsey, L.L., et al.
Publicado: (2023)

Nonlymphoma hematological malignancies in systemic lupus erythematosus
por: Lu, M, et al.
Publicado: (2012)

A Case of Lupus Erythematosus of the Face and Body, with Superinduced Epitheliomata of the Face
por: Dyer, Isadore
Publicado: (1892)

Lung cancer in systemic lupus erythematosus
por: Kale, M, et al.
Publicado: (2012)

Psychosocial Experiences of Adolescent Girls and Young Women Subsequent to an Abortion in Sub-saharan Africa and Globally: A Systematic Review
por: Zia, Yasaman, et al.
Publicado: (2021)

Cell of origin in diffuse large B-cell lymphoma in systemic lupus erythematosus: molecular and clinical factors associated with survival
por: Tessier-Cloutier, Basile, et al.
Publicado: (2019)

A Rare Case of Kikuchi Fujimoto's Disease with Subsequent Development of Systemic Lupus Erythematosus
por: Zuo, Yu, et al.
Publicado: (2012)

A Rare Case of Male Bullous Lupus Erythematosus Complicated with Subsequent Annular Hypopigmentation
por: Itoi, Saori, et al.
Publicado: (2014)

PB2066: SYSTEMIC LUPUS ERYTHEMATOSUS-INDUCED AMEGAKARYOCYTIC THROMBOCYTOPENIA AND SUBSEQUENT APLASTIC ANEMIA
por: Seong, Gyuhee, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_11dpclt1jm8dec6uva8nghm2ut